Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.20.2
Stock-Based Compensation
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Stock-Based Compensation
NOTE 9—STOCK-BASED COMPENSATION
At its Annual Meeting held on June 3, 2020, the Company’s shareholders approved the Company’s 2020 Stock Incentive Plan (the “2020 Plan”), and the 2020 Plan became effective on that date following such approval. The 2020 Plan replaced the Company’s 1997 Stock Incentive Plan (the "Prior Plan”) and no new awards will be granted under the Prior Plan. The terms and conditions of the awards granted under the Prior Plan will remain in effect with respect to awards granted under the Prior Plan. The Company has reserved 3 million shares of common stock for issuance under the 2020 Plan, plus up to an aggregate of 1.5 million shares of the Company’s common stock that were previously authorized and available for issuance under the Prior Plan. The 2020 Plan allows for grants of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock units, and other stock-based or cash-based awards.
Stock-based compensation expense
Stock-based compensation expense consisted of the following:
  Three Months Ended September 30, Nine Months Ended September 30,
(in thousands) 2020 2019 2020 2019
Stock options $ 1,775  $ 1,509  $ 5,234  $ 4,600 
Restricted stock units 3,315  2,869  7,568  8,559 
Total $ 5,090  $ 4,378  $ 12,802  $ 13,159 
Stock Options
During the nine months ended September 30, 2020, the Company granted a total of 660,071 stock options at a weighted average grant date fair value of $14.67. As of September 30, 2020, unrecognized costs related to outstanding stock options totaled $13.3 million, before any related tax benefit. As of September 30, 2020, unrecognized costs related to stock options are expected to be recognized over a weighted average period of 2.59 years.
Restricted Stock Units
During the nine months ended September 30, 2020, the Company granted 209,972 restricted stock units at an estimated average grant date fair value of $79.43. As of September 30, 2020, unrecognized costs related to outstanding restricted stock units totaled $21.5 million, before any related tax benefit. As of September 30, 2020, unrecognized costs related to restricted stock units are expected to be recognized over a weighted average period of 2.34 years.